These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15861673)

  • 1. [Antigen presentation mediated by class I major histocompatibility complex].
    Ueno T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():304-8. PubMed ID: 15861673
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunology: professional secrets.
    Roy CR
    Nature; 2003 Sep; 425(6956):351-2. PubMed ID: 14508466
    [No Abstract]   [Full Text] [Related]  

  • 3. How do endogenous proteins become peptides and reach the endoplasmic reticulum.
    Nandi D; Marusina K; Monaco JJ
    Curr Top Microbiol Immunol; 1998; 232():15-47. PubMed ID: 9557392
    [No Abstract]   [Full Text] [Related]  

  • 4. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of autophagy in MHC class I antigen presentation.
    Øynebråten I
    Scand J Immunol; 2020 Nov; 92(5):e12978. PubMed ID: 32969499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses?
    Garbi N; Tanaka S; van den Broek M; Momburg F; Hämmerling GJ
    Immunol Rev; 2005 Oct; 207():77-88. PubMed ID: 16181328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology. Nothing 'gainst time's scythe can make defense..
    Ploegh HL
    Science; 2004 May; 304(5675):1262-3. PubMed ID: 15166355
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudomonas aeruginosa Cif protein enhances the ubiquitination and proteasomal degradation of the transporter associated with antigen processing (TAP) and reduces major histocompatibility complex (MHC) class I antigen presentation.
    Bomberger JM; Ely KH; Bangia N; Ye S; Green KA; Green WR; Enelow RI; Stanton BA
    J Biol Chem; 2014 Jan; 289(1):152-62. PubMed ID: 24247241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
    Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
    Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
    Udono H; Ichiyanagi T; Mizukami S; Imai T
    Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?
    Yewdell JW; Antón LC; Bennink JR
    J Immunol; 1996 Sep; 157(5):1823-6. PubMed ID: 8757297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary and functional perspectives of the major histocompatibility complex class I antigen-processing machinery.
    Paulsson KM
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2446-60. PubMed ID: 15526153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational characterization of the peptidome in transporter associated with antigen processing (TAP)-deficient cells.
    Martín-Galiano AJ; López D
    PLoS One; 2019; 14(1):e0210583. PubMed ID: 30645615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.
    Leone P; Shin EC; Perosa F; Vacca A; Dammacco F; Racanelli V
    J Natl Cancer Inst; 2013 Aug; 105(16):1172-87. PubMed ID: 23852952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are ERAD components involved in cross-presentation?
    Grotzke JE; Cresswell P
    Mol Immunol; 2015 Dec; 68(2 Pt A):112-5. PubMed ID: 26005101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagosomes are competent organelles for antigen cross-presentation.
    Houde M; Bertholet S; Gagnon E; Brunet S; Goyette G; Laplante A; Princiotta MF; Thibault P; Sacks D; Desjardins M
    Nature; 2003 Sep; 425(6956):402-6. PubMed ID: 14508490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cross-presentation pathway].
    Kimura Y; Inaba K
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():309-14. PubMed ID: 15861674
    [No Abstract]   [Full Text] [Related]  

  • 19. Perpetual complexity: predicting human CD8
    Di Carluccio AR; Triffon CF; Chen W
    Immunol Cell Biol; 2018 Apr; 96(4):358-369. PubMed ID: 29424002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.
    Hammer GE; Gonzalez F; Champsaur M; Cado D; Shastri N
    Nat Immunol; 2006 Jan; 7(1):103-12. PubMed ID: 16299505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.